Showing results (1991-2000 of 7,557) with videos related to

Sort By:
Pageof 756
Molecular Pharmaceutics|August 27, 2014
Antibacterial activities of amphiphilic cyclic cell-penetrating peptides against multidrug-resistant pathogensDonghoon Oh, Jiadong Sun, Amir Nasrolahi Shirazi, et al.
Molecular Pharmaceutics|August 27, 2014
PET imaging of neovascularization with (68)Ga-3PRGD2 for assessing tumor early response to Endostar antiangiogenic therapyJiyun Shi, Zhongxia Jin, Xujie Liu, et al.
Molecular Pharmaceutics|August 27, 2014
One-pot multi-tracer synthesis of novel (18)F-labeled PET imaging agentsAnna Haslop, Lisa Wells, Antony Gee, et al.
Molecular Pharmaceutics|September 3, 2014
Effects of surface displayed targeting ligand GE11 on liposome distribution and extravasation in tumorHailing Tang, Xiaojing Chen, Mengjie Rui, et al.
Molecular Pharmaceutics|September 3, 2014
Adjuvant cationic liposomes presenting MPL and IL-12 induce cell death, suppress tumor growth, and alter the cellular phenotype of tumors in a murine model of breast cancerIsmail M Meraz, David J Savage, Victor Segura-Ibarra, et al.
Molecular Pharmaceutics|August 29, 2014
Effect of surface functionality of silica nanoparticles on cellular uptake and cytotoxicitySiddharth Jambhrunkar, Zhi Qu, Amirali Popat, et al.
Molecular Pharmaceutics|April 7, 2016
Monitoring the Collapse of pH-Sensitive Liposomal Nanocarriers and Environmental pH Simultaneously: A Fluorescence-Based ApproachSören Draffehn, Michael U Kumke
Molecular Pharmaceutics|May 26, 2016
Dual-Functional Nanoparticles Targeting CXCR4 and Delivering Antiangiogenic siRNA Ameliorate Liver FibrosisChun-Hung Liu, Kun-Ming Chan, Tsaiyu Chiang, et al.
Molecular Pharmaceutics|June 11, 2016
Combining Stimulus-Triggered Release and Active Targeting Strategies Improves Cytotoxicity of Cytochrome c Nanoparticles in Tumor CellsMoraima Morales-Cruz, Alejandra Cruz-Montañez, Cindy M Figueroa, et al.
Molecular Pharmaceutics|June 14, 2016
Silk-Elastinlike Protein Polymer Liquid Chemoembolic for Localized Release of Doxorubicin and SorafenibAzadeh Poursaid, Mark Martin Jensen, Ida Nourbakhsh, et al.
Pageof 756